Particle.news
Get it on Google Play
Download on the App Store
7 ARTICLES
·
4h ago

Kenya Confirms Third Bundibugyo Ebola Case Linked to Imported Fatality

The new case raises the risk of further cross-border spread because point-of-entry screening gaps and strained outbreak resources could hamper containment.

A Kenyan health worker checks the temperatures of travelers crossing from Uganda to Kenya as part of measures to contain the spread of Ebola virus, in Busia, Kenya, Thursday, Oct. 15, 2026. (AP Photo/Andrew Kasuku)
Image
A medical worker directs motorcyclists to the health port at the Malaba crossing-point between Kenya and Uganda after a man who had been living in the Democratic Republic of Congo travelled and died of a new Ebola outbreak involving the Bundibugyo species at the Nairobi Hospital, in Malaba, Kenya October 8, 2026. REUTERS/Jackson Adika
People disinfect their hands as a Kenyan health worker checks the temperatures of travelers crossing from Uganda to Kenya as part of measures to contain the spread of Ebola virus, in Busia, Kenya, Thursday, Oct. 15, 2026. (AP Photo/Andrew Kasuku)

Overview

  • Kenya’s health ministry confirmed on Friday that a 65-year-old relative of the first patient tested positive for the Bundibugyo strain while in quarantine, bringing the country’s total to three linked cases.
  • All three Kenyan cases are epidemiologically tied to an imported patient who arrived from the DRC and died in Nairobi, and officials say there is no evidence of wider community transmission.
  • Authorities have traced and placed most listed contacts in quarantine—reporting figures such as 127 of 130 people located—but a small number remain untraced and some passengers who traveled via Uganda are difficult to locate.
  • WHO, Africa CDC and partners have supplied training, personal protective equipment and lab support to Kenya and have praised contact tracing while advising against travel bans.
  • The cases reflect wider risks from the large DRC Bundibugyo outbreak, which has caused thousands of cases and deaths, has no licensed vaccine, and is being constrained by funding shortfalls, access limits and public trust and legal disputes that could slow the response.